Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-23

Clinical Trial Update: Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial compares enzalutamide to bicalutamide in men with prostate cancer to assess comparative safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Casodex (bicalutamide)
  • Xtandi (enzalutamide)

Snippet

Sponsor: Pfizer | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-05-23